With 1200 international participants , the EMIM has significantly grown while preserving its collaborative, inclusive, and lively atmosphere. It is packed with excellent science and serves as a comprehensive and inspiring platform for multidisciplinary …

Cardiovascular diseases are the most frequent causes of death in the United States. Scientists at the University of Missouri School of Medicine, the Department of Medical Pharmacology and Physiology, Dalton Cardiovascular Research Center, College of …

INOVAIT and the Imaging Network Ontario are coming together in 2025 to host a joint medical imaging, image-guided therapy, and artificial intelligence symposium bringing in the next generation of researchers and industry experts. … … IGT x ImNO …

Small animal models are now an integral part of pharmaceutical drug discovery and development prior to commercialization. Small animal imaging is an efficient and cost-effective research platform for the timely validation of novel drug agents. These …

Experience the Vevo F2 LAZR-X20, our most powerful, and customizable multi-modal in vivo imaging platform. The multi-modal Vevo F2 LAZR-X20 is the ultimate solution for advanced tissue characterization with high anatomical accuracy. See and measure …

The 22 nd DGJM will focus on innovative approaches in cardiovascular research, with a particular emphasis on the latest breakthroughs in understanding cardiac diseases and the development of innovative, personalized therapies. This year, the meeting will …

The HFpEF Summit is a bi-annual, two-day meeting which brings together internationally recognized leaders in the areas of clinical, translational and biological studies of heart failure with preserved ejection fraction (HFpEF). This summit is focused on …